Glutamatergic innervation of the heart initiates retrograde contractions in adult Drosophila melanogaster.
The adult abdominal heart of Drosophila melanogaster receives extensive innervation from glutamatergic neurons at specific cardiac regions during metamorphosis. Here, we show that the neurons form presynaptic specializations, as indicated by the localization of synaptotagmin and active zone markers, adjacent to postsynaptic sites that have aggregates of glutamate IIA receptors. To determine the role of this innervation in cardiac function, we developed an optical technique, based on the movement of green fluorescent protein-labeled nerve terminals, to monitor heart beat in intact and semi-intact preparations. Simultaneous monitoring of adjacent cardiac chambers revealed the direction of contractions and allowed correlation with volume changes. The cardiac cycle is composed of an anterograde beat in alternation with a retrograde beat, which correlate respectively with systole and diastole of this multichambered heart. The periodic change in hemolymph direction is referred to as cardiac reversal. Intracellular recordings from muscles of the first abdominal cardiac chamber, the conical chamber, revealed pacemaker action potentials and the excitatory effect of local glutamate application, which initiated retrograde contractions in semi-intact preparations. Unilateral electrical stimulation of the transverse nerve containing the glutamatergic neuron that serves the conical chamber caused a chronotropic effect and initiation of retrograde contractions. This effect is distinct from that of peripheral crustacean cardioactive peptide (CCAP) neurons, which potentiate the anterograde beat. Cardiac reversal was evoked pharmacologically by sequentially applying CCAP and glutamate to the heart.
Dulcis
Davide
D
Arizona Research Laboratories Division of Neurobiology, University of Arizona, Tucson, Arizona 85721-0077, USA. dulcis@neurobio.arizona.edu
Levine
Richard B
RB
D000375:Aging / Q000502:physiology; D000818:Animals; D030801:Animals, Genetically Modified; D004331:Drosophila melanogaster / Q000502:physiology*; D004558:Electric Stimulation; D018698:Glutamic Acid / Q000502:physiology*; D006321:Heart / Q000187:drug effects / Q000294:innervation; D007150:Immunohistochemistry; D009200:Myocardial Contraction / Q000502:physiology; D009479:Neuropeptides / Q000494:pharmacology; D018091:Receptors, AMPA / Q000502:physiology; D013569:Synapses / Q000502:physiology
D009479:Neuropeptides; D018091:Receptors, AMPA; C058620:crustacean cardioactive peptide; D018698:Glutamic Acid; C104722:glutamate receptor ionotropic, AMPA 2